© 2025 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Latest Conference Articles
Hand, Foot, and Mouth Disease Update: A Conversation with Elizabeth Swanson, MD
March 13th 2025
Elizabeth Swanson, MD, discusses the changing face of HFMD, focusing on the increasingly prevalent coxsackievirus A6 strain and its unique characteristics
JiaDe Yu, MD: When to Refer Pediatric Patients with Suspected Contact Dermatitis
March 13th 2025
In an interview at AAD 2025, Dr Yu emphasized the importance of managing contact dermatitis early and effectively to prevent long-term complications.
Advances in Understanding of Itch: A Conversation with Brian S Kim, MD, MTR, at the 2025 AAD Meeting
March 12th 2025
Brian S Kim, MD, a leading investigator in the study of itch physiology, discusses the marked progress made in understanding the sensation and targeting its treatment.
Atopic Dermatitis of Childhood Onset Significantly Impacts "Life Trajectory" According to Scars of Life Survey
March 12th 2025
The impact of childhood onset AD on adult psychosocial experience, including employment and the decision to become a parent, is profound, this study reveals.
Advances in Dermatology Therapeutics: Key Insights from AAD 2025
March 11th 2025
Highlights include new data on roflumilast cream 0.15%, an investigational anti-OX40 ligand monoclonal antibody, and more.
JiaDe Yu, MD: Key Signs of Allergic Contact Dermatitis in Children
March 11th 2025
AAD 2025. JiaDe Yu, MD, discusses key clinical signs of pediatric ACD, when to consider patch testing, and how identifying contact allergens can improve patient care.
Elizabeth Swanson, MD: When HSV Causes Big Dermatologic Problems
March 10th 2025
Elizabeth Swanson, MD, breaks down the role of the Herpes Simplex Virus in 3 special circumstances, part of her AAD 2025 presentation, "Big Rashes In Little Patients."
For Atopic Dermatitis, "The Treatment Drought is Over," Says Expert Dermatologist Emma Guttman, MD, PhD
March 10th 2025
AAD 2025. Guttman, among the world's foremost researchers in dermatology, toplined how far the field has come in her "Hot Topics" presentation on the final day of the 2025 AAD.
Delgocitinib Data Reveal "Super Responders" in CHE During AAD 2025 Late Breaker
March 10th 2025
Data on delgocitinib from the DELTA development program highlight efficacy of the topical JAK inhibitor for treatment of chronic hand eczema.
Recognizing Allergic Contact Dermatitis in Children: Expert Pearls at AAD 2025
March 10th 2025
JiaDe Yu, MD, shares key takeaways from his presentation on pediatric allergic contact dermatitis.